Risk identification and management: MRI as a research tool in toxicology studies of new chemical entities
Prog Drug Res
.
2005:62:257-78.
doi: 10.1007/3-7643-7426-8_7.
Authors
Mark W Tengowski
1
,
John J Kotyk
Affiliation
1
Pfizer Global Research and Development, Pfizer, Inc., 12800 Plymouth Road 16-1A/6, Ann Arbor, MI 48105, USA. mark.w.tengowski@pfizer.com
PMID:
16329259
DOI:
10.1007/3-7643-7426-8_7
No abstract available
MeSH terms
Animals
Brain / drug effects
Drug Evaluation, Preclinical*
Heart / drug effects
Humans
Kidney / drug effects
Liver / drug effects
Magnetic Resonance Imaging*
Risk Assessment
Toxicology*